Seneca backs Vizibl

The founder and MD of a SaaS platform which has secured household names and millions in funding in just three years has said its global ambitions must be handled with care.

Alex Short, MD and co-founder of Vizibl, told BusinessCloud that the company now counts four of the top ten pharma companies in the world and Vodafone among its clients, along with a recent major FinTech win described as a “stake in the ground”.

The company’s potential has been recognised with the backing of Seneca Partners, who have provided a £2m injection of funding to the business, which has 25 people in its London office, supported with offices in Luxembourg, and a satellite office in New York.

Since founding Vizibl in 2013, then known as Old St. Labs, the company has quickly grown an appetite for bigger fish. Short singled out Apple as a company it would like to reach.

“We’re not scared of going in there and rubbing shoulders with the big boys. To date, it is what has proven out our business model and why we’ve had the investment,” he said.

Read the article in full at

Investing in private companies puts your capital at risk and you should seek advice before making an investment. Unquoted shares are by their nature illiquid and may not be sold easily and may not be sold for value.

Important notice

The contents of this website are a financial promotion and are approved by Seneca Partners Limited of 9 The Parks, Newton-le-Willows WA12 0JQ.

The value of an investment in the Seneca Capital Growth VCT plc may go down as well as up, in which case an investor may not get back the amount invested. The share prices quoted may not reflect the VCT’s net asset value.

Seneca Growth Capital VCT plc’s investments include holdings in private companies which are small and which carry an above-average level of risk to capital and whose shares may not be readily marketable. It also invests in companies quoted on the Alternative Investment Market (AIM) of the London Stock Exchange (LSE) which is generally for smaller, emerging companies and carries a higher level of risk to capital than the main market of the LSE.  The past performance of Seneca Growth Capital VCT plc is not a guide to the future performance.

Any tax reliefs available to investors are dependent on personal circumstances and may change in the future. The tax reliefs available to certain investors in Seneca Growth Capital VCT plc are dependent on the VCT maintaining Inland Revenue approval. If this approval is withdrawn, the VCT will lose its status and all tax reliefs are likely to be cancelled. Investors must retain their VCT shares for five years to retain the up-front income tax relief. The tax rules and regulations governing VCTs are subject to change.

An investment in Seneca Growth Capital VCT plc may not be suitable for all investors. Investors should seek advice from a qualified financial adviser. Nothing on this website should be construed as investment or tax advice.

Seneca Partners Ltd is authorised and regulated by the Financial Conduct Authority.